OrangeDigm.com -digm shift
Guide a revolutionary new way of
Work , love and life-style plan.
You deserve the right tools and
principles to guide you to a
better
job,
love, and
e business.
New
anti-impotence drug approved
News Source : Food & Drug
Administration
Seoul, Nov 29 2005 (Korea Newswire)--
The Korea Food and Drug Administration (KFDA) approved a
local pharmaceutical company’s anti-impotence drug on
Tuesday (Nov. 29) and the market of erectile dysfunction
medicines dominated by imported drugs is expected to enter
fierce competition.
“We have approved the Dong-A Pharmaceutical’s Zydena (100
milligram and 200 milligram pill), an erectile dysfunction
medicine. And the drug is the first of its kind developed by
the Korean company,” said a KFDA official.
It took eight years for the company to develop the drug with
an investment of 20 billion won, the food and drug regulator
said, adding that the medicine has become the 10th
domestically developed new drug.
With an approval from the Food and Drug Administration (FDA)
of the United States, Zydena has been under a phase 2
clinical test there since March, the KFDA said.
“Patients with a doctors’ prescription will be able to buy
the medicine from Dec. 12. The company aims at servicing
over 20 percent of the market next year,” Bang Seock-june, a
product manager of the company, said.
The debut of the medicine is expected to change the map of
the erectile dysfunction drug market dominated by
multinational giants.
The Dong-A will attach the price tag at 7,000 won for a 100
milligram pill and at 12,000 won for a 200 milligram pill
while other companies’ medicines priced at over 11,000 won
for the 100 milligram category.
An official at the Dong-A company said that as its marketing
strategy, it will accentuate the fact that Zydena has been
developed with Koreans in mind in contrast with three other
foreign drugs that dominate the Korean market.
